A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer. (Q52863110)
Jump to navigation
Jump to search
scientific article published on 18 August 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer. |
scientific article published on 18 August 2015 |
Statements
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer (English)
Johanna C Bendell
Konstanze Diefenbach
John Lettieri
Oliver Boix
A Craig Lockhart
Cindy O'Bryant
Kathleen N Moore
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference